 Hemodynamic events prospective trial propranolol versus placebo prevention first variceal hemorrhage double-blind randomized trial hemodynamic events administration propranolol placebo cirrhotic patients esophageal varices hepatic venous pressure gradient heart rate variceal size baseline months beginning therapy Baseline values similar groups months hepatic venous pressure gradient propranolol-treated patients mm Hg patients placebo mm Hg NS subsequent time intervals gradient baseline value groups Heart rate propranolol-treated group times Variceal hemorrhage patients placebo- propranolol-treated hepatic venous pressure gradient mm Hg patients propranolol- placebo-treated hepatic venous pressure gradient equal mm Hg none esophageal varices mortality rate bleeding events first year placebo- propranolol-treated protective effect period reduction hepatic venous pressure gradient reduction hepatic venous pressure gradient mm Hg protects variceal bleeding rate survival aim pharmacological therapy portal hypertension